(Q36527862)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Peter Valent

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Luis Escribano

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

Current Allergy and Asthma Reports

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

282-288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).

26 December 2019

cites work

1 reference

12 December 2020

Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.

1 reference

12 December 2020

Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry

1 reference

12 December 2020

Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications

1 reference

12 December 2020

Mastocytosis: current concepts in diagnosis and treatment

1 reference

12 December 2020

A monoclonal antibody to a human mast cell/myeloid leukaemia-specific antigen binds to normal haemopoietic progenitor cells and inhibits colony formation in vitro

1 reference

12 December 2020

Clinical and histopathological aspects of cutaneous mastocytosis

1 reference

12 December 2020

Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.

1 reference

12 December 2020

Expression of alpha-tryptase and beta-tryptase by human basophils

1 reference

12 December 2020

Mast cell proliferative disorders: current view on variants recognized by the World Health Organization

1 reference

12 December 2020

Systemic mastocytosis

1 reference

12 December 2020

Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues.

1 reference

12 December 2020

Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils

1 reference

12 December 2020

Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia

1 reference

12 December 2020

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

1 reference

12 December 2020

Significance of systemic mast cell disease with associated hematologic disorders

1 reference

12 December 2020

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

1 reference

12 December 2020

A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias

1 reference

12 December 2020

Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma

1 reference

12 December 2020

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

1 reference

12 December 2020

Mastocytosis: pathology, genetics, and current options for therapy

1 reference

12 December 2020

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders

1 reference

12 December 2020

Mastocytosis: mediator-related signs and symptoms

1 reference

12 December 2020

Paediatric mastocytosis

1 reference

12 December 2020

Diagnostic criteria and classification of mastocytosis: a consensus proposal

1 reference

12 December 2020

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome

1 reference

12 December 2020

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness

1 reference

12 December 2020

1 reference

12 December 2020

Diagnostic value of immunostaining for tryptase in patients with mastocytosis

1 reference

12 December 2020

Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes

1 reference

12 December 2020

Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis

1 reference

12 December 2020

PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects

1 reference

12 December 2020

Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis

1 reference

12 December 2020

Determination of rat mast cells by flow-cytometry.

1 reference

12 December 2020

Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia

1 reference

12 December 2020

Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.

1 reference

12 December 2020

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

1 reference

12 December 2020

Detection of novel CD antigens on the surface of human mast cells and basophils

1 reference

12 December 2020

Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors

1 reference

12 December 2020

Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis

1 reference

12 December 2020

Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder

1 reference

12 December 2020

The biology of Kit in disease and the application of pharmacogenetics

1 reference

12 December 2020

Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders

1 reference

12 December 2020

Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells.

1 reference

12 December 2020

Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.

1 reference

12 December 2020

Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis

1 reference

12 December 2020

10.1007/S11882-006-0061-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16822380%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference